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Introduction
An important question for the Ras biologist is whether the
ubiquitously expressed, almost identical Ras isoforms have
distinct functions. Because of the high degree of sequence
homology (>90%) shared by the three main expressed isoforms
(H-Ras, N-Ras and K-Ras4B)*, it has long been assumed that
they are functionally redundant. This view is reinforced by
observations that all Ras isoforms share common sets of
downstream effectors and upstream guanine-nucleotide-
exchange factors (GEFs). We have only recently begun to
appreciate that differences in the cellular requirements for
these Ras isoforms do exist and that signaling through each Ras
isoform can result in distinct biochemical outcomes. 
Early studies of the frequency of Ras mutation in human
cancer revealed that specific Ras isoforms are often
preferentially activated in particular malignancies: for
example, K-Ras in pancreatic and colonic carcinomas and
N-Ras in acute leukaemia (Bos, 1989). More compelling
observations came from transgenic experiments showing that
only K-Ras is essential for normal mouse development. H-Ras
or N-Ras knockouts have no observable side effects (Umanoff
et al., 1995; Koera et al., 1997), whereas a K-Ras knockout is
embryonic lethal at 12-14 days of gestation: embryos show
late-onset growth and hemopoietic defects (Johnson et al.,
1997; Koera et al., 1997). Several recent studies have also
identified distinct signal outputs from different Ras isoforms.
For example, in BHK and COS cells, H-Ras and K-Ras display
distinct effector activation profiles: K-Ras is a more potent
activator of Raf-1 than is H-Ras, and the converse is true for
activation of phosphoinositide 3-kinase (PI3K; Yan et al.,
1998). In addition, activated alleles of H-Ras, N-Ras and K-
Ras transform NIH3T3 and Rat1 cells with varying potencies
(Voice et al., 1999), and N-Ras appears to have a unique role
in suppressing apoptosis in cultured primary fibroblasts
(Wolfman and Wolfman, 2000). 
How can these biological differences be explained? H-Ras,
N-Ras and K-Ras have identical sequences covering the
effector, exchange factor and guanine-nucleotide-binding
domains. The only region of the Ras isoforms that exhibits
significant sequence divergence is the final 24 residues of the
protein, the hypervariable region (HVR), which exhibits
approximately 10-15% conservation compared with >90%
identity over the N-terminal 165 residues (see Fig. 1). Ten
years ago, the HVR was shown to contain two signal sequences
that cooperate in targeting Ras to the plasma membrane.
The first signal sequence is the CAAX box (C=cysteine,
A=aliphatic amino acid, X=serine or methionine) present at the
extreme C-terminus (Willumsen et al., 1984; Hancock et al.,
1989). The CAAX box is sequentially post-translationally
modified to render it more hydrophobic: the cysteine is
farnesylated, the AAX sequence is removed by proteolysis, and
then the now-C-terminal cysteine is carboxylmethylated. The
second signal sequence consists of a polybasic stretch of six
lysine residues (175-180) in K-Ras, or palmitoylation of
cysteine 181 in N-Ras, or of cysteines 181 and 184 in H-Ras
(Hancock et al., 1990; Hancock et al., 1991). We discuss the
role of the remainder of the HVR, the so-called linker domain
(see Fig. 1), below. Correct subcellular localization is critical
for Ras function, since effectors such as Raf, RalGDS and
PI3K must be recruited specifically to the plasma membrane
for activation (for reviews, see Morrison and Cutler, 1997;
Campbell et al., 1998; Vojtek and Der, 1998). Thus, interfering
with Ras plasma membrane localization, by mutating the
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The Ras GTPases operate as molecular switches that link
extracellular stimuli with a diverse range of biological
outcomes. Although many studies have concentrated on the
protein-protein interactions within the complex signaling
cascades regulated by Ras, it is becoming clear that the
spatial orientation of different Ras isoforms within the
plasma membrane is also critical for their function. H-Ras,
N-Ras and K-Ras use different membrane anchors to
attach to the plasma membrane. Recently it has been shown
that these anchors also act as trafficking signals that direct
palmitoylated H-Ras and N-Ras through the exocytic
pathway to the cell surface but divert polybasic K-Ras
around the Golgi to the plasma membrane via an as yet-
unidentified-route. Once at the plasma membrane, H-Ras
and K-Ras operate in different microdomains. K-Ras
is localized predominantly to the disordered plasma
membrane, whereas H-Ras exists in a GTP-regulated
equilibrium between disordered plasma membrane and
cholesterol-rich lipid rafts. These observations provide a
likely explanation for the increasing number of biological
differences being identified between the otherwise highly
homologous Ras isoforms and raise interesting questions
about the role membrane microlocalization plays in
determining the interactions of Ras with its effectors and
exchange factors. 
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*There are two alternatively spliced forms of K-Ras: K-Ras4A and K-Ras4B. It is the 4B
isoform that is ubiquitously expressed and for the purpose of clarity we refer to K-Ras4B
as K-Ras for the rest of this commentary.
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CAAX box, or the second signal, or through the use of
farnesyltransferase inhibitors, abrogates Ras signaling
(Willumsen et al., 1984; Gutierrez et al., 1989; Hancock et al.,
1989; Cadwallader et al., 1994; Jackson et al., 1994; Gibbs et
al., 1997).
An important consequence of HVR divergence is that the
plasma membrane anchors of H-Ras, N-Ras and K-Ras are all
different, albeit only in palmitoylation stoichiometry in the
case of N-Ras and H-Ras. Biological differences between the
Ras isoforms could therefore be due in part to differences in
plasma membrane microlocalization. Here, we discuss recent
work that has provided substantial support for this hypothesis.
In particular, we focus on how Ras proteins are trafficked to
the plasma membrane via different routes and how differential
localization to distinct plasma membrane microdomains
influences Ras function.
The role of the endoplasmic reticulum in Ras
trafficking
The CAAX motif of newly synthesized Ras is farnesylated in
the cytosol by farnesyl protein transferase, an enzyme cloned
and characterized a decade ago. More recently the other
mammalian CAAX-processing enzymes have been cloned on
the basis of sequence homology shared with their previously
identified yeast homologs. AAX proteolysis of farnesylated
CAAX peptides is carried out by Rce1 (homologous to
Afc1p/Ste24p and Rce1p in yeast; Boyartchuk et al., 1997;
Schmidt et al., 1998; Tam et al., 1998; Otto et al., 1999). a -
Carboxylmethylation of farnesylated cysteine residues is
carried out by Icmt (homologous to Ste14p in yeast; Marr et
al., 1990; Hrycyna et al., 1991; Dai et al., 1998). Interestingly,
both Rce1 and Icmt are ER-resident proteins; thus the two final
steps of post-translational processing of the farnesylated
CAAX motif must occur on the cytosolic surface of ER
membranes. Rce1 knockouts and Icmt knockouts are lethal late
in mouse embryonic development (at 15.5 days or 10.5-12.5
days respectively; Kim et al., 1999; Bergo et al., 2001). No
obvious cause of death was observed in Rce1-null embryos,
but Icmt-null embryos are much smaller than wild type. The
more severe phenotype might be due to the additional role of
Icmt in the post-translational processing of Rab proteins. Ras
proteins in Rce1-null fibroblasts are partially mislocalized to
the cytosol, which is consistent with a role for Rce1 in Ras
trafficking.
Protein palmitoyltransferase activity has been identified in
multiple cellular locations, depending on the protein substrate
used in the assay (Gutierrez and Magee, 1991; Berthiaume and
Resh, 1995; Dunphy et al., 1996; Das et al., 1997). Recent data,
however, suggest that the enzyme that palmitoylates newly
synthesized, CAAX-processed H-Ras may be localized to the
ER (Apolloni et al., 2000), although biochemical purification,
and hence characterization, of this enzyme is proving
extremely difficult (Liu et al., 1996). Indeed, under certain
conditions in vitro, non-enzymatic palmitoylation can occur,
prompting debate as to whether there is actually a requirement
for enzymatic catalysis (Duncan and Gilman, 1996; Bano et al,
1998). Similarly, a Ras palmitoyltransferase has not yet been
isolated from yeast, although genetic screens have identified
two proteins, Erf2p and Shr5p, that are involved in the
palmitoylation process (Jung et al., 1995; Bartels et al., 1999).
Deletion of Erf2p or Shr5p impairs Ras palmitoylation and
causes partial mislocalization of Ras to the vacuole. Erf2p,
which has numerous uncharacterized mammalian homologs, is
also localized to the ER (Bartels et al., 1999). Thus although
total cellular palmitoyltransferase activity is unaffected in
Erf2p- or Shr5p-null cells (Jung et al., 1995; Bartels et al.,
1999), a smaller Ras-specific ER pool of palmitoyltransferase
might nevertheless be compromised. 
A final point about Ras palmitoylation is that it is reversible
– palmitate on N-Ras and H-Ras turns over with a half-life of
20 min and 60 min, respectively (Magee et al., 1987 and
Hancock, unpublished data) – in contrast to farnesylation,
which is irreversible. Experiments with N-Ras have shown
that, in the absence of secretory transport, plasma membrane
localization is maintained, which suggests that there may be
plasma membrane palmitoyltransferase activity that can
efficiently re-palmitoylate de-acylated N-Ras (Schroeder et al.,
1997).
Trafficking from the ER to the plasma membrane
An important question raised by the localization of CAAX-
processing enzymes to the ER is how Ras proteins access the
plasma membrane from the ER after post-translational
modification. This question has now been solved for H-Ras and
N-Ras. Two recent papers showed that N-Ras and H-Ras are
distributed throughout the classical secretory pathway (Choy
et al., 1999; Apolloni et al., 2000). Brefeldin A (BFA) causes
ER accumulation of these proteins, and a 15°C temperature
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Fig. 1. Ras hypervariable regions. The diagram shows the
degree of sequence conservation between isoforms along
the Ras protein; all of the effector, exchange factor and
nucleotide-binding sites are found in the N-terminal
conserved domains. The hypervariable region (HVR) is the
only region of significant divergence between the Ras
proteins and exhibits <10-15% sequence identity between
any two isoforms. The HVR can be divided into two
domains: the membrane-targeting domain and the linker
domain. The membrane-targeting domain comprises the
C-terminal CAAX motif, common to all Ras proteins, plus
second signal sequences: cysteine palmitoylation sites
(shown in red) in H-Ras, N-Ras and K-Ras4A or a
polybasic domain in K-Ras4B (shown in red and
underlined). Note that in the text K-Ras refers to K-Ras4B.
H-Ras
N-Ras
K-Ras4A
K-Ras4B
Farnesyl, palmitate
Farnesyl, palmitate
Farnesyl, palmitate
Farnesyl
Lipid modificationHypervariable region
Membrane-targeting
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Linker domain
100% 90% 10-15%
1 85 165 188/189
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YRMKKLNSSDDGTQGCMGLPCVVM
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block causes H-Ras to accumulate in the intermediate
compartment between the ER and Golgi. These data
convincingly demonstrate that palmitoylated Ras proteins
access the plasma membrane by vesicular trafficking through
the classical exocytic pathway. In contrast to conventional
cargo carried in vesicle lumens, however, H-Ras and N-Ras
must be transported on the cytoplasmic surface of vesicles. 
In contrast to H-Ras and N-Ras, polybasic K-Ras is largely
excluded from the Golgi and is transported to the plasma
membrane via a route that is insensitive to temperature blocks
or BFA. Palmitoylation or a polybasic domain is essential for
efficient transport, because non-palmitoylated H-Ras and N-
Ras mutants, and K-Ras mutants that lack the polybasic
sequence, accumulate in the ER. These and other data strongly
suggest that the second targeting signal in the HVR determines
the route taken by the different Ras proteins out of the ER to
the plasma membrane. The polybasic domain might therefore
function as a novel ER-exit signal to divert the K-Ras through
an uncharacterized, Golgi-independent pathway to the plasma
membrane (see Fig. 2; Choy et al., 1999; Apolloni et al., 2000).
Importantly, these studies also reveal the minimal nature of the
trafficking signals: chimeras containing the H-Ras, N-Ras and
K-Ras plasma membrane targeting sequences fused to green
fluorescent protein (GFP) traffic exactly like the cognate full-
length Ras proteins.
The nature of the K-Ras trafficking pathway remains elusive
and is under intense study. Some intriguing observations
have been made, although their significance remains to be
established. Treatment of NIH-3T3 cells with the microtubule
stabilizer paclitaxel results in accumulation of K-Ras but not
H-Ras in an uncharacterized but apparently vesicular
compartment (Thissen et al., 1997). In addition K-Ras, but no
other Ras or Ras-related protein, binds to taxol-stabilized
microtubules in vitro. The polybasic domain of K-Ras
mediates this microtubule binding (Chen et al., 2000), but
it is currently unclear how microtubules are involved in
intracellular trafficking of K-Ras, especially given that electron
microscopic and immunofluorescent analysis of taxol-treated
cells found no close association of K-Ras with microtubules,
but instead showed accumulation of K-Ras in endosomes
(Apolloni et al., 2000). The high-affinity electrostatic
interactions between K-Ras and the plasma membrane (see
below) and the close proximity of the ER to the plasma
membrane in most cells have led other investigators to propose
that K-Ras reaches the plasma membrane through simple
passive diffusion from the ER rather than any specific protein-
based transport mechanism (Roy et al., 2000). In this scenario,
the polybasic domain does not operate as a formal ER exit
signal but merely provides the necessary charge to drive K-ras
diffusion to the negatively charged plasma membrane. 
Here, we have focused predominantly on Ras processing
and trafficking, but note that essentially the same C-terminal
signal sequences are present in Rho family small GTPases.
All Rho proteins have a C-terminal CAAX motif that is
geranylgeranylated*, and then AAX proteolysed and
methylesterified by Rce1 and Icmt. RhoB and TC10 are also
palmitoylated, Rac1 and RhoA contain strongly polybasic
sequences, and Cdc42 and Rac2 are weakly polybasic. Although
these proteins contain targeting motifs similar to those of H-Ras,
N-Ras or K-Ras, they nevertheless localize to a diverse range of
subcellular locations – for example, RhoB localizes to the
plasma membrane and Golgi, RhoA localizes to the cytosol, and
Cdc42 localizes to the ER and Golgi (Michaelson et al., 2001).
Thus, the trafficking routes to the plasma membrane followed
by palmitoylated or polybasic Ras proteins represent default
pathways dictated by the minimal C-terminal sequences of
Ras-related CAAX proteins, but protein-protein interactions
occurring elsewhere in the protein must be able to modulate final
intracellular localization. For example, the localization of the
non-palmitoylated Rho family members, particularly RhoA, is
influenced by the cytosolic chaperone RhoGDI (Michaelson et
al., 2001). Additional support for this hypothesis comes from
observations that Rap1a localizes to the Golgi (Beranger et al.,
1991), whereas the C-terminal 16 residues of Rap1a target GFP
*The CAAX motif of RhoB can be farnesylated or geranylgeranylated.
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Fig. 2. Trafficking and plasma membrane localization of H-
Ras and K-Ras. Following CAAX modification of both
isoforms in the ER K-Ras takes an uncharacterized Golgi-
independent route to the disordered plasma membrane. By
contrast, H-Ras traffics via the classical secretory pathway
through the Golgi to caveolae and lipid rafts. H-Ras then
exists in a dynamic equilibrium between lipid rafts and the
disordered plasma membrane. The HVR linker domain has
a critical role in this equilibrium. Activation of H-Ras on
GTP-loading shifts the equilibrium in favor of residence in
the disordered plasma membrane. N-Ras (not shown)
traffics to the plasma membrane, in common with H-Ras,
but its plasma membrane microlocalization has not yet been
established.
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efficiently to the plasma membrane (Roy et al., 2000). In
addition, Cdc42 is now known to bind to the g -subunit of
coatomer on COP1-coated vesicles, which could stabilize its
interaction with the ER and Golgi compartments rather than the
plasma membrane (Wu et al., 2000). 
Plasma membrane microdomains and Ras function
One possible consequence of the alternative trafficking
pathways used by Ras proteins is that their ultimate
microlocalizations within the plasma membrane might also
differ. This hypothesis is conceptually more straightforward
now that the simple fluid mosaic model of the plasma
membrane has been superceded by a more complex structure
that includes microdomains that have distinct protein and lipid
compositions. The best-studied microdomain is the lipid raft,
which comprises sphingolipids and glycosphingolipids packed
together with cholesterol (for reviews, see Simons and Ikonen,
1997; Hooper, 1999; Kurzchalia and Parton, 1999). A key
biophysical property of lipid rafts is their liquid-ordered
structure, which promotes phase separation from the more
loosely packed, disordered glycerophospholipids of the bulk
plasma membrane. Peripheral membrane proteins anchored by
long, saturated acyl chains that readily pack into the liquid
domain structure are able to associate with lipid rafts: for
example, glycophosphatidylinositol (GPI)-anchored proteins
and certain Src family kinases that reside in the outer and inner
leaflets of the plasma membrane, respectively (for reviews, see
Simons and Ikonen, 1997; Hooper, 1999; Kurzchalia and
Parton, 1999; Simons and Toomre, 2000). By contrast, proteins
anchored solely by farnesyl or geranylgeranyl groups are
excluded from lipid rafts, because the branched, unsaturated
prenoid chain cannot incorporate into a liquid-ordered
structure (Melkonian et al., 1999; Moffett et al., 2000). This
division of the plasma membrane into raft and non-raft
compartments clearly presents a framework for differential
lateral segregation of the Ras isoforms. However, whereas
K-Ras, anchored by a combination of prenylation and
electrostatic interaction with the plasma membrane, would
not be expected to have any affinity for raft domains, the
microdomain localizations of H-Ras and N-Ras, which are
anchored by a combination of palmitoylation and prenylation,
are much harder to predict. 
The first insights into Ras microlocalization really came with
observations that disrupting lipid raft structure, by chemically
depleting plasma membrane cholesterol, selectively abrogates
H-Ras- but not K-Ras-mediated activation of Raf-1 (Roy et al.,
1999). Expression of a dominant-negative caveolin mutant,
caveolin-DGV, which reduces cell surface cholesterol by
interfering with intracellular cholesterol transport (Pol et al.,
2001), also blocks H-Ras but not K-Ras signaling pathways
(Roy et al., 1999). The simplest interpretation of these results
is that H-Ras and K-Ras occupy distinct microdomains of the
plasma membrane and that the functional integrity of the H-
Ras domain depends on cholesterol.
Another study has now examined the plasma membrane
distributions of H-Ras and K-Ras by using a combination of
biochemistry and electron and light microscopy (Prior et al.,
2001). This showed that GFP targeted to the plasma membrane
by the polybasic domain and CAAX motif of K-Ras associates
neither with caveolae, a distinct, morphologically identifiable
subtype of lipid raft, nor with non-caveolar lipid rafts*.
Similarly, full-length K-Ras in the GDP-bound ground state,
or activated GTP-bound state, has an identical distribution to
that of GFP-targeted by the K-Ras motifs: that is, it resides in
the disordered, non-raft plasma membrane (Prior et al., 2001).
By contrast, the palmitoylation sequence and CAAX motif
of H-Ras targets GFP very efficiently to caveloae and non-
caveolar lipid rafts. Intriguingly, although the minimal
targeting motif of H-Ras sequesters all of the GFP to lipid rafts,
GDP-bound full-length H-Ras is distributed approximately
equally between lipid rafts and bulk plasma membrane, and
constitutively activated GTP-bound H-Ras is localized
predominantly to non-raft bulk plasma membrane. Mutational
analysis of H-Ras reveals that the HVR linker domain has a
critical role in liberating H-Ras from lipid rafts, since deletion
of these sequences completely confines activated H-Ras to
lipid rafts (Prior et al., 2001).
The model that best fits the data is shown in Fig. 2. H-Ras
is initially trafficked to caveolae and lipid rafts, but then exists
in a dynamic equilibrium between lipid rafts and the disordered
plasma membrane. GTP loading shifts this equilibrium in favor
of residence in the bulk plasma membrane. The precise
mechanism regulating H-Ras lateral segregation is unknown,
but it does not require interactions with known Ras effectors,
and therefore a conformational change in H-Ras, induced by
GTP loading, is probably transmitted through to the membrane
anchor to reduce raft affinity. Such a mechanism would explain
the essential role of the HVR linker domain in the process and
in a sense is consistent with recent work showing that
prenylation influences the structure of the N-terminal GTPase
domains of H-Ras (Williams et al., 2000); thus a ‘reverse’
influence of GTP-induced conformational changes on the C-
terminus seems quite plausible. Reversible raft association is
not without precedent: the EGF receptor migrates from lipid
rafts to clathrin-coated pits upon activation (Mineo et al.,
1999), and fluorescent studies of raft dynamics have shown that
lipid probes continually exchange between liquid-ordered and
disordered membrane domains (Schutz et al., 2000).
The differential localization of H-Ras and K-Ras clearly has
important potential consequences for effector interactions and
activation of downstream pathways. This is well illustrated by
some preliminary data comparing Raf-1 activation by activated
H-Ras with that by an H-Ras HVR mutant confined to lipid
rafts. Raf-1 can be recruited equally well to disordered plasma
membrane and lipid rafts, but Raf activation is much less
efficient in raft domains than in bulk plasma membrane (Prior
et al., 2001). In addition, Booden et al. have recently shown
that mutations in the H-Ras HVR can alter the efficiency with
which H-Ras activates its various effectors (Booden et al.,
2000). Although this latter study did not evaluate whether these
mutations change the plasma membrane microlocalization of
H-Ras, it is tempting to speculate that this is the underlying
mechanism. 
A large body of evidence suggests that the polybasic
domain of K-Ras promotes plasma membrane binding by
an electrostatic interaction with acidic phospholipids. For
example, mutational analyses of the polybasic domain have
shown that if the overall net charge and amphiphilic character
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*Lipid rafts can exist in the plane of the plasma membrane (as non-caveolar lipid rafts)
or be aggregated by the structural protein caveolin into invaginations of the plasma
membrane called caveolae (for a detailed review, see Simons and Toomre, 2000).
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is retained, the protein will associate with the plasma
membrane (Hancock et al., 1990; Hancock et al., 1991;
Jackson et al., 1994; Roy et al., 2000). This electrostatic
mechanism is supported by biophysical measurements of the
interactions between charged prenylated peptides and artificial
membranes (Murray et al., 1999; Arbuzova et al., 2000; Roy
et al., 2000). Furthermore, measurements of K-Ras lateral
mobility in the plasma membrane show that K-Ras movement
is relatively unrestricted (Niv et al., 1999). The plasma
membrane consists of 20-30 mol% acidic lipids. A recent
analysis of protein-lipid electrostatic interactions suggested
that polybasic domains could attract acidic lipids and
concentrate them in localized areas, which could in turn
facilitate the recruitment or activation of other proteins
(Murray et al., 1999). Does the presence of K-Ras in the
plasma membrane therefore actually create an acidic
microdomain in which it then operates? Since acidic
phospholipids include phosphatidylserine, which is required
for Raf activation, and phosphatidylinositols, the substrates for
another Ras effector, PI3K, such K-Ras-defined microdomains
within the bulk plasma membrane could turn out to be
important ‘mini-signaling centers’.
Conclusions and perspectives
Recent insights into the mechanisms of Ras trafficking and
plasma membrane localization have answered some important
questions but inevitably posed new ones. We now understand
how H-Ras and N-Ras traffic to the plasma membrane, but the
discovery of the novel Golgi-independent route taken by K-Ras
presents a new challenge. K-Ras is the most frequently mutated
Ras isoform in human cancers; it is also less susceptible than
other Ras isoforms to drugs that target farnesyltransferase.
Understanding the mechanisms of K-Ras trafficking could
identify new targets for anticancer therapies.
The dynamic association of H-Ras with caveolae and lipid
rafts is particularly intriguing. In the light of these discoveries,
it will be interesting to investigate whether protein sequences
adjacent to lipid anchors and/or protein conformation regulate
the association of other acylated proteins with lipid rafts.
Important questions regarding the mode of association of H-
Ras with lipid rafts and caveolae also still remain. Precursors
to these domains are known to form within the TGN, and it
will be interesting to discover whether H-Ras associates with
lipid rafts at this point.
K-Ras is targeted to non-raft areas of the plasma
membrane, but speculation that the polybasic domain can
recruit acidic phospholipids and generate de novo signaling
centers, if validated, could introduce a new level of
complexity to the mechanisms of K-Ras signaling. We must
also examine how the distinct microlocalizations of H-Ras
and K-Ras and N-Ras (once established) influence their
access to exchange factors and their ability to interact with
defined effector proteins. The recent studies outlined above
represent the starting point for such work. Finally, although
there still many unanswered questions, it is quite clear that
differential lateral segregation of the Ras isoforms in the
plasma membrane underlies the biological differences
between these proteins. This highlights the importance in
future of considering the cell biology of H-Ras, N-Ras and
K-Ras individually rather than collectively.
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helpful discussions. JFH is supported by the National Health and
Medical Research Council (Australia), the Queensland Cancer Fund
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